Amarnani, R., Travis, S., & Javaid, M. (2020). Novel use of burosumab in refractory iron-induced FGF23-mediated hypophosphataemic osteomalacia. Oxford University Press.
Lua i Stíl Chicago (17ú heag.)Amarnani, R., S. Travis, agus MK Javaid. Novel Use of Burosumab in Refractory Iron-induced FGF23-mediated Hypophosphataemic Osteomalacia. Oxford University Press, 2020.
Lua MLA (9ú heag.)Amarnani, R., et al. Novel Use of Burosumab in Refractory Iron-induced FGF23-mediated Hypophosphataemic Osteomalacia. Oxford University Press, 2020.
Rabhadh: Seans nach mbeach na luanna seo go hiomlán cruinn i ngach uile chás.